| 标题 |
Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Infectious Diseases 作者:Paul Kim; Ana M. Sánchez; Taylor J.R. Penke; Hannah H. Tuson; J. Kime; et al 出版日期:2024-08-09 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)